Patanjali said it had not received a copy of the order.
Pharmaceutical company Divya Pharmacy, owned by yoga guru Baba Ramdev’s Patanjali group, on Thursday accused an “anti-Ayurveda drug mafia” of conspiracy after the Uttarakhand government reportedly banned the production of five of their drugs citing misleading advertising.
The company said it had not received a copy of the order, which is cited in the top newspaper reports, but “the involvement of the anti-Ayurvedic drug mafia is clear”.
“All products and medicines manufactured by Patanjali are manufactured to prescribed standards and comply with all legal processes and international standards with the highest research and quality in the Ayurveda tradition with the help of more than 500 scientists,” the company said in a statement.
“The letter, which was conspiratively written and circulated in the media on 11/09/2022 in a sponsored manner by Ayurveda and Unani Services Uttarakhand, has not been made available to Patanjali Sansthan in any form,” she added.
“Either the department should correct its mistake and take appropriate action against the person involved in this conspiracy, otherwise the organization will take legal action to punish the individuals responsible for this conspiracy along with compensation for the institutional loss that Patanjali,” the company said.
According to reports in several newspapers on Thursday, Uttarakhand Ramdev’s Patanjali Ayurved authorities had asked to stop manufacturing five products the company advertised to treat blood pressure, diabetes, goiter, glaucoma and high cholesterol.
The Ayurveda and Unani Licensing Authority in Dehradun, Uttarakhand, ordered manufacturer Divya Pharmacy to cease production of Madhugrit, Eyegrit, Thyrogrit, BPgrit and Lipidom advertised as part of Patanjali’s Ayurveda health product range, The Telegraph reported.
The order was given by Dr. GCS granted. Jangpangi, Licensing Officer of Uttarakhand Ayurvedic and Unani Services, and accused Patanjali of misleading advertising, The Hindu reported.
According to the Hindustan Times, the measure was taken in response to a complaint filed by Kerala-based ophthalmologist KV Babu earlier this July. KV Babu emailed another complaint to the State Licensing Authority (SLA) on Oct. 11, the newspaper said.